Clinical Trials Browser

Phase 1 × Solid Tumors, KRAS Mutation; SOS1 × 90 days × Clear all

NCT04111458 2026-01-12

A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors, KRAS Mutation; SOS1